サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1493336

患者支援技術の市場規模、シェア、動向分析レポート：タイプ別、地域別、セグメント予測、2024年～2030年

Patient Support Technology Market Size, Share & Trends Analysis Report By Type (Standalone, Integrated), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
患者支援技術の市場規模、シェア、動向分析レポート：タイプ別、地域別、セグメント予測、2024年～2030年
出版日: 2024年05月27日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

患者支援技術市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の患者支援技術市場は2024年から2030年にかけて10.7%のCAGRを記録し、2030年には32億米ドルに達する見込みです。

包括的な患者中心のソリューションに対する要求の高まり、ヘルスケアシステムによるデジタルヘルスケアソリューションの採用の増加、技術の進歩、市場参入企業による戦略的進歩への積極的な参加が、市場成長の原動力になると予測されます。

さらに、モバイルヘルスアプリケーションまたはmヘルスアプリケーションは、患者支援技術市場の成長を加速させる上で重要な役割を果たしています。これらのアプリケーションは、服薬リマインダー、健康モニタリング、症状追跡、バーチャル相談など多様な機能を提供します。これらのアプリケーションは、ヘルスケア管理への積極的な関与を可能にし、健康習慣を促進し、ヘルスケアプロバイダーとのシームレスなコミュニケーションを促進することで、患者を勇気づける。スマートフォンとウェアラブルデバイスの使用の増加は、mヘルスアプリの採用を増幅し、患者支援技術エコシステムの不可欠なコンポーネントとしての地位を確固たるものにしています。

IQVIAによると、利害関係者にとって最適な結果を求める企業は、患者支援プログラム（PSP）技術への投資戦略をEESI（EASY）の目標に合わせるべきです。これらの目標は、患者やケアパートナーとのエンゲージメントの強化、サービスチーム間のコラボレーションの促進、ユーザーエクスペリエンスの簡素化、患者転帰改善のためのインサイト生成の強化に重点を置いています。この連携には、患者とケア・パートナーの積極的な参加、効果的なコミュニケーション、意思決定の共有の促進、サービス・チーム間のシームレスなチームワークとコミュニケーションの促進、ユーザビリティ向上のための直感的なインターフェイスの設計、実用的な洞察を導き出しワークフローを合理化するためのデータ駆動型アプローチの活用が含まれます。PSPテクノロジー投資戦略をEESI（EASY）の目標と統合することで、企業は患者エンゲージメントを高め、チームコラボレーションを強化し、ユーザーエクスペリエンスを合理化し、患者の転帰を改善することができます。

さらに、テクノロジーはプログラムのパフォーマンス測定を強化する可能性を提供し、患者の転帰に実用的な評価を組み込むことを可能にします。このテクノロジーは、長期にわたる治療成績を徹底的に調査するために利用され、長期にわたる治療中の患者の転帰を評価するのに役立ちます。さらに、AIと機械学習主導の技術プラットフォームは、患者の多様なニーズを分析し、よりカスタマイズされたパーソナライズされた体験を可能にします。患者サポートのライフサイクルのさまざまな段階にわたって革新的な技術を統合することは、データと高度な分析を通じて患者のニーズを包括的に洞察する機会を提供します。

2023年9月、マイクロソフト社とマーシーは、ジェネレーティブAIとデジタル技術の活用で提携し、ヘルスケアプロバイダーが患者ケアにより多くの時間を割けるようにし、患者体験を向上させることを可能にしました。AIが支援するジェネレーティブ・コミュニケーションは、理解しやすい検査結果を提供し、十分な情報に基づいた話し合いを促進することで、患者に力を与えます。さらに、チャットボットは、マーシーの同僚が必要な情報に迅速にアクセスできるよう支援し、看護師やスタッフが患者ケアにより集中できるようにします。

患者支援技術市場のレポートハイライト

  • タイプ別では、包括的なソリューションが利用可能で、患者中心のケアに重点が置かれていることから、統合型セグメントが2023年の市場を独占しました。
  • 北米が2023年の収益シェア41.12%で世界市場を独占。この成長の背景には、政府のイニシアチブの高まり、ヘルスケア産業における技術進歩、主要市場プレイヤーの強力なプレゼンスがあります。
  • 患者支援技術市場は競争が激しく、さまざまな企業が市場シェア強化のために新製品投入、提携、買収などの戦略を採用しています。例えば、ZSは2023年10月、ZAIDYN by ZSプラットフォームの一部であるAI搭載のZAIDYN Connected Healthソリューションを発表しました。ZAIDYN Connected Healthは、製薬会社、ヘルスケアプロバイダー、支払者が、満たされていないニーズを理解し、患者とのより良い関係を築き、健康アウトカムを改善するためのイノベーションを支援します。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 患者支援技術市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • 患者支援技術市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響

第4章 患者支援技術市場：タイプの推定・動向分析

  • タイプ別市場シェア、2023年と2030年
  • セグメントダッシュボード
  • 世界の患者支援技術市場タイプ別展望
  • スタンドアロン
  • 統合型

第5章 患者支援技術市場：地域の推定・動向分析、タイプ別

  • 地域別市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 世界地域市場スナップショット
  • 市場規模と予測動向分析、2018年から2030年
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
    • イノベーター
    • 主要販売代理店およびチャネルパートナーのリスト
    • 主要顧客
    • 主要企業の市場シェア分析、2023年
    • Deloitte
    • Accenture
    • McKesson Corporation
    • Cardinal Health
    • DataRiver S.r.l
    • Medisafe
    • Inizio Engage
    • AssistRx
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America patient support technology market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 4 U.S. patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 5 Canada patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 6 Europe patient support technology market, by region, 2018 - 2030 (USD Million)
  • Table 7 Europe patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 8 Germany patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 9 UK patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 10 France patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 11 Italy patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 12 Spain patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 13 Denmark patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 14 Sweden patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 15 Norway patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific patient support technology market, by region, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 18 China patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 19 Japan patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 20 India patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 21 South Korea patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 22 Australia patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 23 Thailand patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 24 Latin America patient support technology market, by region, 2018 - 2030 (USD Million)
  • Table 25 Latin America patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 26 Brazil patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 27 Mexico patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 28 Argentina patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 29 MEA patient support technology market, by region, 2018 - 2030 (USD Million)
  • Table 30 MEA patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 31 South Africa patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 33 UAE patient support technology market, by type, 2018 - 2030 (USD Million)
  • Table 34 Kuwait patient support technology market, by type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Patient support technology market: market outlook
  • Fig. 9 Patient support technology competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Patient support technology market driver impact
  • Fig. 15 Patient support technology market restraint impact
  • Fig. 16 Patient support technology market strategic initiatives analysis
  • Fig. 17 Patient support technology market: Type movement analysis
  • Fig. 18 Patient support technology market: Type outlook and key takeaways
  • Fig. 19 Standalone market estimates and forecast, 2018 - 2030
  • Fig. 20 Integrated market estimates and forecast, 2018 - 2030
  • Fig. 21 Global patient support technology market: Regional movement analysis
  • Fig. 22 Global patient support technology market: Regional outlook and key takeaways
  • Fig. 23 Global patient support technology market share and leading players
  • Fig. 24 North America market share and leading players
  • Fig. 25 Europe market share and leading players
  • Fig. 26 Asia Pacific market share and leading players
  • Fig. 27 Latin America market share and leading players
  • Fig. 28 Middle East & Africa market share and leading players
  • Fig. 29 North America: SWOT
  • Fig. 30 Europe SWOT
  • Fig. 31 Asia Pacific SWOT
  • Fig. 32 Latin America SWOT
  • Fig. 33 MEA SWOT
  • Fig. 34 North America market estimates and forecasts, 2018 - 2030
  • Fig. 35 U.S. key country dynamics
  • Fig. 36 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 37 Canada key country dynamics
  • Fig. 38 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 39 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 40 UK key country dynamics
  • Fig. 41 UK market estimates and forecasts, 2018 - 2030
  • Fig. 42 Germany key country dynamics
  • Fig. 43 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 44 France key country dynamics
  • Fig. 45 France market estimates and forecasts, 2018 - 2030
  • Fig. 46 Italy key country dynamics
  • Fig. 47 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 48 Spain key country dynamics
  • Fig. 49 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 50 Denmark key country dynamics
  • Fig. 51 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 52 Sweden key country dynamics
  • Fig. 53 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 54 Norway key country dynamics
  • Fig. 55 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 57 China key country dynamics
  • Fig. 58 China market estimates and forecasts, 2018 - 2030
  • Fig. 59 Japan key country dynamics
  • Fig. 60 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 61 India key country dynamics
  • Fig. 62 India market estimates and forecasts, 2018 - 2030
  • Fig. 63 Thailand key country dynamics
  • Fig. 64 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 65 South Korea key country dynamics
  • Fig. 66 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 67 Australia key country dynamics
  • Fig. 68 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 69 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 70 Brazil key country dynamics
  • Fig. 71 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 72 Mexico key country dynamics
  • Fig. 73 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 74 Argentina key country dynamics
  • Fig. 75 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 76 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 77 South Africa key country dynamics
  • Fig. 78 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 79 Saudi Arabia key country dynamics
  • Fig. 80 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 81 UAE key country dynamics
  • Fig. 82 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 83 Kuwait key country dynamics
  • Fig. 84 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 85 Key company categorization
  • Fig. 86 Company market position analysis, 2023
  • Fig. 87 Strategy mapping
目次
Product Code: GVR-4-68040-284-8

Patient Support Technology Market Growth & Trends:

The global patient support technology market is expected to reach USD 3.2 billion by 2030, registering a CAGR of 10.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing requirement for comprehensive patient-centric solutions, increasing adoption of digital healthcare solutions by healthcare systems, technological advancements, and active participation in strategic advancements by the market players are expected to drive market growth.

Furthermore, mobile health applications or mHealth apps are playing a crucial role in accelerating the growth of the patient support technology market. These applications provide diverse functionalities, including medication reminders, health monitoring, symptom tracking, and virtual consultations. They encourage patients by enabling active engagement in their healthcare management, promoting healthy habits, and facilitating seamless communication with healthcare providers. The rising use of smartphones and wearable devices amplifies the adoption of mHealth apps, solidifying their position as an essential component of the patient support technology ecosystem.

According to IQVIA, companies seeking optimal outcomes for stakeholders should align their investment strategy in Patient Support Program (PSP) technology with the EESI (EASY) goals. These objectives emphasize enhancing patient and care partner engagement, fostering collaboration among service teams, simplifying user experiences, and enhancing insight generation for improved patient outcomes. This alignment involves promoting active participation, effective communication, and shared decision-making among patients and their care partners, facilitating seamless teamwork and communication across service teams, designing intuitive interfaces for enhanced usability, and leveraging data-driven approaches to derive actionable insights and streamline workflows. By integrating their PSP technology investment strategy with the EESI (EASY) goals, companies can elevate patient engagement, enhance team collaboration, streamline user experiences, and drive better patient outcomes.

Furthermore, technology offers the potential to enhance program performance measurement, enabling the incorporation of practical assessments into patient outcomes. This technology is utilized to conduct thorough investigations into longitudinal performance, aiding in evaluating patient outcomes during therapy over extended periods. Furthermore, AI and machine learning-driven technology platforms analyze patients' diverse needs, enabling a more customized and personalized experience. Integrating innovative technologies across different stages of the patient support lifecycle presents an opportunity to gain comprehensive insights into patient needs through data and advanced analytics.

In September 2023, Microsoft Corp. and Mercy partnered to utilize generative AI and digital technologies, enabling healthcare providers to devote more time to patient care and enhance the patient experience. Generative AI-assisted communication empowers patients by providing understandable lab results and facilitating informed discussions. Additionally, the chatbot aids Mercy co-workers in swiftly accessing essential information, allowing nurses and staff to focus more on patient care.

Patient Support Technology Market Report Highlights:

  • Based on type, the integrated segment dominated the market in 2023, owing to the availability of a comprehensive solution and increased focus on patient-centered care.
  • North America dominated the global market with a revenue share of 41.12% in 2023. The growth is attributed to the increasing government initiative, technological advancement in the healthcare industry, and a strong presence of key market players.
  • The patient support technology market is competitive, and various players are adopting strategies such as new product launches, partnerships, and acquisitions to strengthen their market share. For instance, in October 2023, ZS launched the AI-powered ZAIDYN Connected Health solution, part of the ZAIDYN by ZS platform. ZAIDYN Connected Health helps pharmaceutical companies, healthcare providers, and payers innovate to understand unmet needs, better engage with patients, and improve health outcomes.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Patient Support Technology Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Patient Support Technology Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & legal landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social & environmental landscape
      • 3.3.2.4. Technological landscape
    • 3.3.3. Impact of COVID-19

Chapter 4. Patient Support Technology Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Patient Support Technology Market by Type Outlook
  • 4.4. Standalone
    • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Integrated
    • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Patient Support Technology Market: Regional Estimates & Trend Analysis, By Type

  • 5.1. Regional Market Share Analysis, 2023 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Global Regional Market Snapshot
  • 5.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 5.5. North America
    • 5.5.1. U.S.
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Canada
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Europe
    • 5.6.1. UK
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.2. Germany
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.3. France
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Regulatory framework/ reimbursement structure
      • 5.6.3.3. Competitive scenario
      • 5.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.4. Italy
      • 5.6.4.1. Key country dynamics
      • 5.6.4.2. Regulatory framework/ reimbursement structure
      • 5.6.4.3. Competitive scenario
      • 5.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.5. Spain
      • 5.6.5.1. Key country dynamics
      • 5.6.5.2. Regulatory framework/ reimbursement structure
      • 5.6.5.3. Competitive scenario
      • 5.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.6. Denmark
      • 5.6.6.1. Key country dynamics
      • 5.6.6.2. Regulatory framework/ reimbursement structure
      • 5.6.6.3. Competitive scenario
      • 5.6.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.7. Sweden
      • 5.6.7.1. Key country dynamics
      • 5.6.7.2. Regulatory framework/ reimbursement structure
      • 5.6.7.3. Competitive scenario
      • 5.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.8. Norway
      • 5.6.8.1. Key country dynamics
      • 5.6.8.2. Regulatory framework/ reimbursement structure
      • 5.6.8.3. Competitive scenario
      • 5.6.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Asia Pacific
    • 5.7.1. Japan
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.2. China
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.3. India
      • 5.7.3.1. Key country dynamics
      • 5.7.3.2. Regulatory framework/ reimbursement structure
      • 5.7.3.3. Competitive scenario
      • 5.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.4. Australia
      • 5.7.4.1. Key country dynamics
      • 5.7.4.2. Regulatory framework/ reimbursement structure
      • 5.7.4.3. Competitive scenario
      • 5.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.5. South Korea
      • 5.7.5.1. Key country dynamics
      • 5.7.5.2. Regulatory framework/ reimbursement structure
      • 5.7.5.3. Competitive scenario
      • 5.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.6. Thailand
      • 5.7.6.1. Key country dynamics
      • 5.7.6.2. Regulatory framework/ reimbursement structure
      • 5.7.6.3. Competitive scenario
      • 5.7.6.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Latin America
    • 5.8.1. Brazil
      • 5.8.1.1. Key country dynamics
      • 5.8.1.2. Regulatory framework/ reimbursement structure
      • 5.8.1.3. Competitive scenario
      • 5.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.2. Mexico
      • 5.8.2.1. Key country dynamics
      • 5.8.2.2. Regulatory framework/ reimbursement structure
      • 5.8.2.3. Competitive scenario
      • 5.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.3. Argentina
      • 5.8.3.1. Key country dynamics
      • 5.8.3.2. Regulatory framework/ reimbursement structure
      • 5.8.3.3. Competitive scenario
      • 5.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. MEA
    • 5.9.1. South Africa
      • 5.9.1.1. Key country dynamics
      • 5.9.1.2. Regulatory framework/ reimbursement structure
      • 5.9.1.3. Competitive scenario
      • 5.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.9.2. Saudi Arabia
      • 5.9.2.1. Key country dynamics
      • 5.9.2.2. Regulatory framework/ reimbursement structure
      • 5.9.2.3. Competitive scenario
      • 5.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.9.3. UAE
      • 5.9.3.1. Key country dynamics
      • 5.9.3.2. Regulatory framework/ reimbursement structure
      • 5.9.3.3. Competitive scenario
      • 5.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.9.4. Kuwait
      • 5.9.4.1. Key country dynamics
      • 5.9.4.2. Regulatory framework/ reimbursement structure
      • 5.9.4.3. Competitive scenario
      • 5.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
    • 6.2.1. Innovators
    • 6.2.2. List of key distributors and channel partners
    • 6.2.3. Key customers
    • 6.2.4. Key company market share analysis, 2023
    • 6.2.5. Deloitte
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Accenture
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. McKesson Corporation
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Cardinal Health
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. DataRiver S.r.l
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives
    • 6.2.10. Medisafe
      • 6.2.10.1. Company overview
      • 6.2.10.2. Financial performance
      • 6.2.10.3. Product benchmarking
      • 6.2.10.4. Strategic initiatives
    • 6.2.11. Inizio Engage
      • 6.2.11.1. Company overview
      • 6.2.11.2. Financial performance
      • 6.2.11.3. Product benchmarking
      • 6.2.11.4. Strategic initiatives
    • 6.2.12. AssistRx
      • 6.2.12.1. Company overview
      • 6.2.12.2. Financial performance
      • 6.2.12.3. Product benchmarking
      • 6.2.12.4. Strategic initiatives